Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 19,289Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4GLAXO GRP LTD

02 3MYLAN SPECIALITY LP

03 15OPTINOSE US INC

04 551TEVA PHARM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 7500444

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21433

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2026-02-26

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 7500444

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21433

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2026-02-26

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 7500444*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21433

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-26

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 7500444*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21433

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-26

blank

05

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 7975690

Drug Substance Claim :

Drug Product Claim :

Application Number : 209022

Patent Use Code : U-2133

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-29

blank

06

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 10076615

Drug Substance Claim :

Drug Product Claim :

Application Number : 209022

Patent Use Code : U-2133

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-07-30

blank

07

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 10478574

Drug Substance Claim :

Drug Product Claim :

Application Number : 209022

Patent Use Code : U-2133

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-11-04

blank

08

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 11602603

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209022

Patent Use Code : U-2133

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-27

blank

09

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 11554229

Drug Substance Claim :

Drug Product Claim :

Application Number : 209022

Patent Use Code : U-2133

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-23

blank

10

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

FLUTICASONE PROPIONATE

US Patent Number : 10300229

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209022

Patent Use Code : U-2133

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-07

blank